异恶唑
化学
三氟甲基
区域选择性
兴奋剂
羧酸盐
环加成
立体化学
化学合成
组合化学
药物化学
受体
有机化学
催化作用
生物化学
体外
烷基
作者
Xiaoping Hou,Juliang Zhu,Bang‐Chi Chen,Scott H. Watterson,William J. Pitts,Alaric J. Dyckman,Percy H. Carter,Arvind Mathur,Huiping Zhang
标识
DOI:10.1021/acs.oprd.6b00112
摘要
This article reports an efficient scale-up synthesis of 1-(4-(5-(3-phenyl-4-(trifluoromethyl)isoxazol-5-yl)-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylic acid (BMS-520), a potent and selective isoxazole-containing S1P1 receptor agonist. This process features a highly regioselective cycloaddition leading to a key intermediate, ethyl 3-phenyl-4-(trifluoromethyl)isoxazole-5-carboxylate, a chemo-selective hydrolysis of its regioisomers, as well as an improved method for 1,2,4-oxadiazole formation, relative to the original synthesis. The improved process was applied to the preparation of multiple batches of BMS-520 for preclinical toxicological studies.
科研通智能强力驱动
Strongly Powered by AbleSci AI